We are live on ! Find out more
EMFAT

Emerald Mutual Fund Advisers Trust Portfolio holdings

AUM $2.85B
1-Year Est. Return 140.52%
This Fund
S&P 500
This Quarter Est. Return
+6.53%
1 Year Est. Return
+140.52%
3 Year Est. Return
+478.17%
5 Year Est. Return
+660.56%
10 Year Est. Return
+4,974.42%
AUM
$1.58B
AUM Growth
-$143M
Cap. Flow
-$168M
Cap. Flow %
-10.64%
Top 10 Hldgs %
18.89%
Holding
232
New
21
Increased
61
Reduced
99
Closed
18

Top Buys

Rank Stock Value
1
BPMC
Blueprint Medicines
BPMC
+$16.3M
2
AHCO icon
AdaptHealth
AHCO
+$14.4M
3
CELH icon
Celsius Holdings
CELH
+$14.3M
4
AMLX icon
Amylyx Pharmaceuticals
AMLX
+$11.8M
5
NOG icon
Northern Oil and Gas
NOG
+$11.5M

Top Sells

Rank Stock Value
1
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$22.5M
2
AVNT icon
Avient
AVNT
+$20M
3
ALKS icon
Alkermes
ALKS
+$18.8M
4
GTLS
Chart Industries
GTLS
+$14.2M
5
ONTO icon
Onto Innovation
ONTO
+$13.1M

Sector Composition

Rank Sector Weight
1 Healthcare 29.23%
2 Financials 15.84%
3 Industrials 14.44%
4 Technology 12.81%
5 Consumer Discretionary 12.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EXPO icon
26
Exponent
EXPO
$3.24B
$19.1M 1.21%
218,100
+102,114
+88% +$9.68M
WHD icon
27
Cactus
WHD
$5.44B
$19M 1.2%
495,592
+81,227
+20% +$3.26M
PLNT icon
28
Planet Fitness
PLNT
$3.78B
$18.3M 1.15%
316,570
-24,149
-7% -$1.74M
CUTR
29
DELISTED
Cutera, Inc.
CUTR
$17.6M 1.11%
385,462
-282
-0.1% -$12.9K
ACAD icon
30
Acadia Pharmaceuticals
ACAD
$5.03B
$16.9M 1.07%
1,032,739
+265,768
+35% +$4.3M
JACK icon
31
Jack in the Box
JACK
$335M
$16.8M 1.06%
227,414
-21,730
-9% -$1.65M
VC icon
32
Visteon
VC
$2.78B
$16.8M 1.06%
158,305
-76,408
-33% -$9.11M
BPMC
33
DELISTED
Blueprint Medicines
BPMC
$16.7M 1.06%
+253,645
New +$16.3M
REPL icon
34
Replimune Group
REPL
$1.01B
$16.7M 1.05%
965,938
-20,332
-2% -$388K
RPD icon
35
Rapid7
RPD
$773M
$16.4M 1.03%
381,542
-80,828
-17% -$4.99M
CRS icon
36
Carpenter Technology
CRS
$28.4B
$16.1M 1.02%
517,312
-31,300
-6% -$1.04M
TMDX icon
37
Transmedics
TMDX
$2.91B
$16M 1.01%
384,447
+37,098
+11% +$1.61M
FWRD icon
38
Forward Air
FWRD
$654M
$15.5M 0.98%
172,183
-14,996
-8% -$1.47M
KTOS icon
39
Kratos Defense & Security Solutions
KTOS
$11.4B
$15.5M 0.98%
1,525,035
+76,685
+5% +$1.03M
MTDR icon
40
Matador Resources
MTDR
$6.09B
$15.2M 0.96%
310,136
+8,980
+3% +$485K
DCGO icon
41
DocGo
DCGO
$62.6M
$15.1M 0.95%
1,520,410
+6,934
+0.5% +$62.6K
CUBI icon
42
Customers Bancorp
CUBI
$2.77B
$15M 0.95%
508,854
-58,640
-10% -$2.08M
ACDC icon
43
ProFrac Holding
ACDC
$787M
$14.6M 0.93%
962,418
+307,114
+47% +$5.53M
CYTK icon
44
Cytokinetics
CYTK
$10.4B
$14.1M 0.89%
291,903
+165,324
+131% +$7.96M
CELH icon
45
Celsius Holdings
CELH
$7.03B
$13.8M 0.87%
+456,735
New +$14.3M
ITGR icon
46
Integer Holdings
ITGR
$4.26B
$13.7M 0.87%
220,894
-23,598
-10% -$1.59M
ATRC icon
47
AtriCure
ATRC
$2.11B
$13.6M 0.86%
349,080
-28,259
-7% -$1.29M
ONT
48
Onterris Inc
ONT
$580M
$13.5M 0.85%
401,731
-14,620
-4% -$580K
SI
49
DELISTED
Silvergate Capital Corporation
SI
$13.4M 0.85%
177,972
-13,001
-7% -$1.11M
AMLX icon
50
Amylyx Pharmaceuticals
AMLX
$2.54B
$13.3M 0.84%
+471,887
New +$11.8M
1
2
3 4 5

Similar funds

SAI
Systematic Alpha Investments Princeton, New Jersey $2.84B AUM 27.03% 1-Year Est. Return
MSDF
Michael & Susan Dell Foundation New York $2.85B AUM 26.28% 1-Year Est. Return
AIP
Atlas Infrastructure Partners London, United Kingdom $2.84B AUM 4.75% 1-Year Est. Return
YC
Yarbrough Capital Franklin, Tennessee $2.85B AUM 36.22% 1-Year Est. Return
AHSSHC
Adventist Health System Sunbelt Healthcare Corp Altamonte Springs, Florida $2.86B AUM 12.86% 1-Year Est. Return
CAM
Crake Asset Management London, United Kingdom $2.86B AUM 16.35% 1-Year Est. Return
GS
GTS Securities New York $2.83B AUM 21.76% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $2.83B AUM 21.61% 1-Year Est. Return

Emerald Mutual Fund Advisers Trust's Q3 2022 Portfolio in Review

As of Q3 2022, Emerald Mutual Fund Advisers Trust held 232 positions worth $1.58B, down 8.3% from $1.73B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Emerald Mutual Fund Advisers Trust withdrew a net $168M in Q3 2022, closing 18 positions and reducing 99 holdings. Its most notable exit was Biohaven Pharmaceutical Holding Company Ltd., an estimated $22.5M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 29% of assets, up from 25% a quarter earlier, followed by Financials and Industrials.

Against the trend, Emerald Mutual Fund Advisers Trust opened a new position in Blueprint Medicines worth $16.7M.

  • Emerald Mutual Fund Advisers Trust's largest Q3 2022 buy was Blueprint Medicines: 253,645 shares worth $16.7M.
  • Emerald Mutual Fund Advisers Trust added most to Northern Oil and Gas in Q3 2022, an estimated $11.5M increase.
  • Emerald Mutual Fund Advisers Trust's biggest Q3 2022 reduction was Avient, cutting an estimated $20M.
  • Emerald Mutual Fund Advisers Trust fully exited Biohaven Pharmaceutical Holding Company Ltd. in Q3 2022, selling an estimated $22.5M.
  • Emerald Mutual Fund Advisers Trust's ten largest holdings make up 19% of its $1.58B portfolio in Q3 2022.
  • Emerald Mutual Fund Advisers Trust opened 21 new positions and closed 18 in Q3 2022.
  • Emerald Mutual Fund Advisers Trust's portfolio value fell 8.3% quarter-over-quarter to $1.58B.

Based on Emerald Mutual Fund Advisers Trust's 13F filing for Q3 2022, filed 25 Oct 2022.